S&P Futures
6,995.00 (+0.17%)
Dow Futures
50,280.00 (+0.12%)
Nasdaq Futures
25,392.00 (+0.15%)
Russell 2000 Futures
2,703.60 (+0.28%)
Crude Oil
64.59 (+0.36%)
Gold
5,071.90 (-0.15%)
Silver
82.18 (-0.07%)
EUR/USD
1.1923 (+0.02%)
10-Yr Bond
4.1980 (-0.19%)
VIX
17.31 (-0.29%)
GBP/USD
1.3674 (-0.13%)
USD/JPY
155.2940 (-0.34%)
Bitcoin USD
69,327.78 (-0.58%)
XRP USD
1.43 (+1.89%)
FTSE 100
10,353.29 (-0.32%)
Nikkei 225
57,650.54 (+2.28%)
Stocks: Losers
| Symbol | Name | Price | Change | Change % | Volume | Avg Volume (3M) | Market Cap | P/E Ratio (TTM) | 52 Wk Change % |
|---|---|---|---|---|---|---|---|---|---|
| FAMI | Farmmi Inc | 0.239 | -0.0360 | -13.0909% | 2227506 | 262412.85245902 | 3799200 | None | -9.811320754717 |
| APLMW | Apollomics Inc. Warrant | 0.02 | 0.0117 | 140.9639% | 2923853 | 81287.704918033 | 23137600 | None | 189.85507246377 |
| BJDX | Bluejay Diagnostics Inc | 1.2 | -0.2400 | -16.6667% | 997096 | 1395346.2295082 | 1821100 | None | 6.1946902654867 |
| EVLVW | Evolv Technologies Holdings Inc | 0.0078 | -0.0027 | -25.7143% | 4825 | 94087.114754098 | 0 | None | -13.333333333333 |
News
Warren Buffett's Berkshire Hathaway has maintained a holding in VeriSign, Inc. (VRSN) since 2012, adjusting its stake over the years. Despite a recent decline in shares due to Berkshire Hathaway's reduction in its stake (attributed to regulatory reasons, not company fundamentals), VeriSign delivered strong first-quarter earnings and raised its full-year revenue guidance. The company benefits from high customer switching costs and US government support.
This article provides an overview of career opportunities and employee benefits at Texas Instruments. It highlights key company facts, employee scorecard ratings, and a comprehensive list of financial, health, wellness, and workplace benefits offered. The article also includes frequently asked questions about the company's policies on international offices, flexible work, internships, job openings, and medical benefits.
Gartner has identified eight top trends in supply chain technology for 2026, driven by advancements in artificial intelligence. These trends are categorized under autonomy and agency, specialization and intelligence, and trust and governance, reflecting a move towards more intelligent, self-directed, and accountable supply chain systems. The report emphasizes the increasing role of AI in creating autonomous, adaptive supply chains and the importance of integrating these technologies to deliver measurable value and resilience.
Pyunghwa Holdings, an automotive parts holding company, has significantly cut its SAP ERP system maintenance costs by over 50% since adopting Rimini Street's third-party support services. This reduction has allowed Pyunghwa Holdings to reinvest savings into AI and digital transformation initiatives, including smart factories and predictive maintenance. Rimini Street provides tailored support, including expertise in Korea-specific SAP HR functions, enabling the company to accelerate its transition to value-creating IT.
The T. Rowe Price Value ETF (TVAL) has achieved its best performance year to date, returning approximately 30% over the last year, coinciding with its third anniversary. This actively managed ETF selects and monitors stocks such as Micron Technology, Exxon, and Bank of America, combining diversification with active management strategies. T. Rowe Price has significantly expanded its ETF offerings, now managing nearly $30 billion in ETF assets, positioning TVAL as a strong, cost-effective, and tax-efficient option for value-oriented investors.
Keysight Technologies and WIN Semiconductors Corp. have announced a joint MMIC design workflow aimed at achieving first-pass tapeout success for GaN MMIC designs. This workflow integrates multi-domain simulation, 3D layout verification, and off-chip MMIC evaluation board design into a single environment, crucial for applications like 5G and satellite systems. The collaboration significantly reduces fabrication risk and accelerates time-to-market for advanced RF products by ensuring comprehensive simulation and optimization before production.
S&P Global (SPGI) recently approved a third-quarter cash dividend of $0.97 per share, reinforcing its income profile despite a significant year-to-date share price decline. Analysts suggest the stock is about 7.5% overvalued with a fair value of $380 per share, influenced by AI-related uncertainty and slower growth expectations in the ratings segment. While the P/E ratio is lower than the industry average, it's higher than peers, prompting investors to consider if the current valuation reflects quality or carries additional risk.
Brodsky & Smith is investigating potential breaches of fiduciary duties by the Boards of LCI Industries (LCII), Iridium Communications Inc. (IRDM), Bio-Techne Corporation (TECH), and Arcosa, Inc. (ACA) in connection with their respective acquisition agreements. The investigations focus on whether the proposed transactions offer fair value to shareholders and if due process was followed. Shareholders are encouraged to contact the firm for more information without cost or obligation.
Teradyne (TER) recently experienced a significant reclassification into major growth indices, including the NASDAQ-100, due to its AI-focused revenue and raised guidance. While this shift impacts how capital tracks the stock, the core investment narrative remains centered on AI-oriented test and automation business growth versus risks like trade volatility. Despite a recent 10.3% stock increase, some analysts suggest a potential downside compared to its current price, highlighting a divergence in valuation perspectives.
Brian Miller, former chief digital officer at Intuitive and now CEO of Sovato, shares insights from his 23-year career in surgical robotics. He advises medtech professionals, especially software engineers, to deeply understand the application and environment where their products will be used. Miller also discusses the evolving dynamics of working at a growing company like Intuitive and the critical mindset required for software development in the medical device industry due to the potential for patient harm.
+0.12%
-0.19%